Co-Founder And Chief Commercial Officer
CurrentKeliomics is an emerging biotech company focused on revolutionizing drug development processes, particularly in the field of cancer treatment. Our innovative organ-scale biology platforms are designed to enhance preclinical testing by preserving human tissues and tumors ex vivo—outside the body—for extended periods. This technology enables a more accurate simulation of human biological responses, helping biopharmaceutical companies better predict a drug's efficacy before moving into clinical trials.We collaborate closely with pharmaceutical companies and academic institutions to accelerate drug development timelines, ensuring that our advanced technologies meet the specific needs of our partners. Our core technologies include the Kelion platform, which maintains the structure and function of primary human tissues, and OncoScreen, which facilitates advanced cancer diagnostics and patient-specific tumor modeling.Join us on our journey to transform drug discovery and improve patient outcomes!Visit us at https://keliomics.com/ to learn more.